Disability patterns over the first year after a diagnosis of epilepsy by Xu, Ying et al.
The University of Notre Dame Australia 
ResearchOnline@ND 
Medical Papers and Journal Articles School of Medicine 
2019 
Disability patterns over the first year after a diagnosis of epilepsy 
Ying Xu 
Dennis R. Neuen 
The University of Notre Dame Australia, dennis.neuen@nd.edu.au 
Nick Glozier 
Armin Nikpour 
Ernest Somerville 
See next page for additional authors 
Follow this and additional works at: https://researchonline.nd.edu.au/med_article 
 Part of the Medicine and Health Sciences Commons 
 
This article was originally published as: 
Xu, Y., Neuen, D. R., Glozier, N., Nikpour, A., Somerville, E., Bleasel, A., Ireland, C., Anderson, C. S., & Hackett, M. L. (2019). Disability 
patterns over the first year after a diagnosis of epilepsy. Clinical Neurology and Neurosurgery, 179, 60-65. 
Original article available here: 
10.1016/j.clineuro.2019.02.022 
This article is posted on ResearchOnline@ND at 
https://researchonline.nd.edu.au/med_article/1020. For more 
information, please contact researchonline@nd.edu.au. 
Authors 
Ying Xu, Dennis R. Neuen, Nick Glozier, Armin Nikpour, Ernest Somerville, Andrew Bleasel, Carol Ireland, 
Craig S. Anderson, and Maree L. Hackett 
This article is available at ResearchOnline@ND: https://researchonline.nd.edu.au/med_article/1020 
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non-
Commercial No Derivatives 4.0 International license (CC BY-NC-ND 4.0), which permits others to 
copy and redistribute the material in any medium or form, provided the original work is properly 
cited. See: https://creativecommons.org/licenses/by-nc-nd/4.0/   
 
This article originally published in the Clinical Neurology and Neurosurgery available 
at: https://doi.org/10.1111/ecc.12985     
 
Xu, Y., Neuen, D.R., Glozier, N., Nikpour, A., Somerville, E., Bleasel, A., Ireland, C., Anderson, C.S., and 
Hackett, M.L. (2019) Disability patterns over the first year after a diagnosis of epilespy. Clinical 
Neurology and Neurosurgery, 179, 60-65. doi:  10.1016/j.clineuro.2019.02.022 
 
 
 
Contents lists available at ScienceDirect
Clinical Neurology and Neurosurgery
journal homepage: www.elsevier.com/locate/clineuro
Disability patterns over the ﬁrst year after a diagnosis of epilepsy
Ying Xua,b, Dennis R. Neuena,c, Nick Glozierd, Armin Nikpourb,e, Ernest Somervillef,
Andrew Bleaselg, Carol Irelandh, Craig S. Andersona,b,e,i,⁎, Maree L. Hacketta,b,j
a The George Institute for Global Health, Faculty of Medicine, University of New South Wales, 83-117 Missenden Road, Camperdown, NSW 2050, Australia
b School of Public Health, Faculty of Medicine and Health, Edward Ford Building (A27) Fisher Road, University of Sydney, NSW 2006, Australia
cWagga Wagga Rural Clinical School, School of Medicine Sydney, University of Notre Dame Australia, 40 Hardy Avenue, Wagga Wagga, NSW 2650, Australia
d Brain and Mind Centre, University of Sydney, 94 Mallett St, Camperdown, NSW 2050, Australia
eNeurology Department, Royal Prince Alfred Hospital, Sydney Local Area Health District, 50 Missenden Rd, Camperdown, NSW 2050, Australia
fNeurology Department, Prince of Wales Clinical School, University of New South Wales, Barker St, Randwick, NSW 2031, Australia
gNeurology Department, Westmead Hospital, Cnr Hawkesbury Road and Darcy Road, Westmead, NSW 2145, Australia
h Epilepsy Action Australia, PO Box 879, Epping, NSW 1710, Australia
i The George Institute China at Peking University Health Science Center, Level 18, Tower B, Horizon Tower, No. 6 Zhichun Rd, Haidian District, Beijing 100088, PR China
j Faculty of Health and Wellbeing, University of Central Lancashire, Preston, PR1 2HE, UK
A R T I C L E I N F O
Keywords:
Epilepsy
Risk factors
Functioning and disability
WHODAS
Emotional
Psychosocial disability
A B S T R A C T
Objective: To determine the patterns and predictors of disability over the ﬁrst 12 months after a diagnosis of
epilepsy.
Patients and methods: The Sydney Epilepsy Incidence Study to Measure Illness Consequences (SEISMIC) was a
prospective, multicenter, community-based study of people with newly diagnosed epilepsy in Sydney, Australia.
Disability was assessed using the World Health Organization’s, Disability Assessment Schedule (WHODAS) 2.0
12-item version, at baseline (i.e. within 28 days of diagnosis) and 12 months post-diagnosis. Demographic,
socioeconomic, clinical and epilepsy-related data, obtained through structured interviews, were entered into
multivariable linear regression and shift analysis to determine predictors of greater disability.
Results: Of 259 adults (≥18 years), 190 (73%) had complete WHODAS at baseline (mean ± SD scores 4 ± 6)
and follow-up (4 ± 8). After adjustment for age, sex and co-morbidity, greater overall disability at 12 months
was associated with lower education (P=0.05), economic hardship (P=0.004), multiple antiepileptic medi-
cations (P=0.02) and greater disability (P < 0.001) at the time of diagnosis; these variables explained 38.3%
of the variance. Among the 12 WHODAS items, “being emotionally aﬀected by health problems” was the most
frequent disability problem identiﬁed at both time points (all P < 0.0001). The proportion of participants
without problems in that domain improved over 12 months (from 24% to 50%, P < 0.0001), whereas the other
11 items remained relatively stable. Independent baseline predictors of a worse emotional outcome at 12 months
were severe/extreme emotional distress (odds ratio [OR] 4.52, 95% conﬁdence intervals [CI] 1.67–12.24),
economic hardship (OR 2.30, 95% CI 1.24–4.25) and perceived stigma (OR 2.02, 95% CI 1.03–3.93).
Conclusion: Most people report problems with emotional health after a diagnosis of epilepsy but many recover
over the next 12 months. Services addressing the social and psychological impact of diagnosis may be needed to
improve outcome.
1. Introduction
Epilepsy is associated with a wide range of psychosocial issues, in-
cluding emotional distress (e.g. depression and anxiety) [1,2], un-
employment [3], driving restrictions [4], stigma [5], low self-esteem
[6], social phobia [7], cognitive dysfunction (e.g. apathy [8], altered
self-identity, memory loss) [9], and marital and family problems [10].
The 2015 International League Against Epilepsy Asia-Oceania Research
Task Force has highlighted the need to alleviate the psychosocial con-
sequences of epilepsy as a research priority [11]. Epilepsy can have a
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critical impact of a person’s life [12], with early frequent emotional
problems and neuropsychological deﬁcits [12–14], and ongoing ﬁ-
nancial burden [15], which can aﬀect adjustment and patterns of dis-
ability. The aim of this study was to quantify disability experienced by
people within the ﬁrst 12 months after a new diagnosis of epilepsy, and
to determine the predictors of greater disability.
2. Patients and methods
Data are from the Sydney Epilepsy Incidence Study to Measure
Illness Consequences (SEISMIC), a prospective multicenter, community-
based study of people with newly diagnosed epilepsy in the me-
tropolitan region of Sydney, Australia. The study is registered
(ANZCTRN12609000059268) and outlined in detail elsewhere
[16–18]. In brief, participants of all ages with a new diagnosis of epi-
lepsy according to centrally adjudicated, standard criteria, were en-
rolled over an initial 6-month pilot phase from July 2008. The re-
cruitment was extended into a 3.5-year main phase from June 2010. All
patients or a legally approved surrogate (usually a family member for
children who were included in the study) provided informed consent,
and ethics committee approvals were obtained from all participating
hospital sites and community clinics. Only adults (≥18 years) were
included in these analyses.
Trained researchers undertook in-person structured interviews with
participants at “baseline” (deﬁned as within 28 days of diagnosis), and
at 12 months follow-up. Participants who had their baseline assess-
ments undertaken beyond the 28-day period were asked to recall their
situation within the ﬁrst month of diagnosis. Information was collected
on socio-demographic characteristics, clinical pattern of seizures and
use of antiepileptic drugs (AEDs). Family function was assessed with the
Family Adaptation, Partnership, Growth, Aﬀection and Resolve
(APGAR) questionnaire, with high scores indicating better family
function [19]. Alcohol consumption was assessed using the World
Health Organization’s Alcohol Use Disorders Identiﬁcation Test (WHO-
AUDIT-c) [20], where a total score of≥5 for males and≥4 for females
indicates ‘at risk’ consumption [16]. Economic hardship was deﬁned as
an instance of a household`s inability to make a necessary household
payment (e.g. gas, electricity or telephone bills, heat or cool home,
mortgage or rent payments) or the demonstration of dissaving behavior
(e.g. borrowing or use of savings, selling assets, borrowing money).
Anxiety and depression were measured using the Hospital Anxiety and
Depression Scale (HADS) subscales [21], with scores of ≥8 on corre-
sponding subscales indicating signiﬁcant anxiety or depression. Per-
ceived stigma was determined by responses to the question “whether
the participant thought that other people are uncomfortable, treat him/
her diﬀerently, or prefer to avoid him/her because of his/her epilepsy”.
Disability was measured using the 12-item WHODAS, with re-
sponses to questions ranging from 0 “none” to 4 “extreme/cannot do”,
where higher scores indicate greater dysfunction and disability in the
last 30 days [22]. We adopted a ‘simple scoring’ method, where the
scores assigned to each item: “none” (0), “mild” (1) “moderate” (2),
“severe” (3) and “extreme/cannot do” (5), were summed. When only
one item had a missing value, the mean of the other items was assigned
as a surrogate score for the missing item. The WHODAS has a thirteenth
question to indicate “How much do these diﬃculties [any endorsed]
interfere with your life?”. The WHODAS 12-item assessment tool has
been shown to be valid and reliable in rating disability [23], and has
been used among people with epilepsy [24–30].
We compared the characteristics of participants with complete
WHODAS scores at baseline and 12-month follow-up (hereafter, re-
ferred to as the study group) with those lost to follow-up or with
missing WHODAS data. Kruskal-Wallis and Chi squared tests were used
for continuous and categorical variables, respectively. Multivariable
linear regression was conducted to determine the variables related to
‘greater overall disability’ at 12 months. Only variables with an asso-
ciation (P < 0.2) with this outcome in univariate models were
considered for inclusion in multivariate models. We used chi-square
tests to compare the distribution of answers to each item on the 12-item
WHODAS at baseline and 12 months, and between each two items at
the same time point. Shift analyses were completed for any item where
statistically signiﬁcantly greater diﬃculty was observed. Only variables
having an association (P < 0.2) with a shift in answers at 12 months
and meeting the proportional odds assumption (P < 0.05) in uni-
variate models, were considered for inclusion in multivariate models. In
multivariable linear regression and shift analyses, if there was high
correlation between variables (deﬁned as> 0.4), only one was entered
into the model. Stepwise removal of non-signiﬁcant covariate identiﬁed
through a Wald test was undertaken until all the remaining variables
were statistically signiﬁcant (P < 0.05). All analyses were undertaken
using SAS Enterprise Version 7.1 (SAS institute, Cary, NC).
3. Results
There were 259 eligible adults with a new diagnosis of epilepsy but
69 (27%) were excluded due to the absence of a valid WHODAS as-
sessment at baseline and/or 12 months. Thus, 190 (73%) remained in
the study group (mean ± SD age 42 ± 18 years, 53% male) with a
mean ± SD baseline total WHODAS score of 4 ± 6 (Table 1 and Fig.
S1). All participants self-completed the clinical and psychosocial as-
sessments but with a nominated proxy present for 14 (7%) at baseline
and 8 (4%) at 12 months. Sixty-ﬁve percent of the study group had
baseline interviews conducted after 28 days post-diagnosis (median 48
days, and interquartile range [IQR] 15–117 days).
Compared to those participants who were lost to follow-up or had
incomplete or missing WHODAS data, the study group were more likely
to be in paid work (P < 0.001), have lower WHODAS scores (i.e. less
disability, P= 0.02) at baseline, and to have waited for ≥8 weeks for
neurologist review (P=0.007). Compared to those who had the base-
line interview conducted within 28 days, more of those who were asked
to recall their situation reported they had seizure frequency more than
several times per year (P=0.02), perceived stigma (P= 0.05), pro-
blems in learning a new task (P=0.02), community activities
(P= 0.02), and maintaining friendship (P= 0.008), and had been on
multiple AEDs (P=0.03) within the ﬁrst month of diagnosis (Table
S1).
As there was a high correlation between age and being a full- or
part-time student (r= 0.47), the latter variable was not included in
models. The right-skewed WHODAS scores (mean ± SD 4 ± 8;
median 1, and IQR 0–4) at 12 months were log transformed (natural
logs). After adjustment for age, sex and co-morbidity, having greater
disability was associated with a lower level of education (i.e. up to
tertiary education, P= 0.05), economic hardship (P=0.004), greater
disability (P < 0.001) and requiring multiple AEDs (P=0.02) at di-
agnosis; these variables explained 38.3% of the variance (Table 2).
Assumptions over linearity, homoscedasticity and normality of re-
siduals, were maintained for this model (Fig. S2).
At both time points, approximately one quarter of the study group
reported some diﬃculties (ranging from mild to extreme/cannot do)
with work and concentration. Around one in ﬁve subjects reported
‘some diﬃculties’ with standing, household responsibilities, learning a
new task, and community activities (Fig. 1). Among the 12 WHODAS
items, “being emotionally aﬀected by health problems” was the most
frequent problem identiﬁed (at both time points, all P < 0.0001).
There was a large reduction in emotional problems, with the proportion
of participants reporting no emotional problems doubling (from 24% to
50%), and the proportion of those who considered their problems to be
severe or extreme, nearly halving from baseline to 12 months post-di-
agnosis (from 13% to 7%, P < 0.0001), whereas the other disability
outcomes were generally stable. Approximately, one third (33%) of
participants reported none or same level of emotional diﬃculties at
both time points; nearly half (48%) improved over 12 months, whilst
one-ﬁfth (19%) reported an increase in such problems (Table S2).
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Responses to the question ‘Overall, how much did these diﬃculties
interfere with your life?’ were very similar to the distribution of re-
sponses to the emotional distress item at baseline and 12 months.
No high correlations were identiﬁed amongst the variables.
Experiencing severe or extreme emotional diﬃculties at baseline (odds
ratio [OR] 4.52, 95% conﬁdence intervals [CI] 1.67–12.24), economic
hardship (OR 2.3, 95% CI 1.24–4.25) and perceived stigma (OR 2.02,
95% CI 1.03–3.93) were the independent predictors of greater emo-
tional problems at 12 months (C statistic 0.68, proportional odds as-
sumption P < 0.0001; Table S3 and Fig. 2). Twenty-ﬁve participants
(13%) reported severe/extreme emotional distress at baseline, 59
(32%) reported economic hardship, and 46 (25%) reported perceived
stigma.
4. Discussion
In this prospective population-based cohort study, after adjustments
were made for age, sex and co-morbidity, the factors that predicted
greater overall disability at 12-months after a diagnosis of epilepsy
were greater baseline disability, lower level of education, economic
hardship, and use of multiple AEDs. Emotional diﬃculties were the
most commonly reported problem, and those experiencing severe/ex-
treme baseline emotional diﬃculties, economic hardship, and per-
ceived stigma at baseline reported more emotional diﬃculties at 12
months.
The SEISMIC WHODAS-12 average total score at diagnosis was
comparable with normative Australia data [31], showing that people
with a physical disorder have scores (mean ± SD 4.3 ± 6.1) lower
Table 1
Participants` characteristics and by attrition.
Variables at baseline (i.e. within 28 days after the diagnosis of epilepsy),
unless speciﬁed
Eligible and consented
(n= 259)
Study group
(n=190)
Lost to follow-up/ invalid
WHODAS (n= 69)
P value
Demographic and socioeconomic
Age, median (IQR), n 38 (26, 57), 259 40 (26, 57), 190 36 (27, 56), 69 0.85
Male 132 (51) 101 (53) 31 (45) 0.24
Married/partnereda 123/236 (52) 100/185 (54) 23/51 (45) 0.26
Up to secondary education 122/240 (51) 98 (52) 24/50 (48) 0.65
Risk drinking level (≥5 for men, ≥4 for women on WHO-AUDIT-c) 73/239 (31) 57/189 (30) 16/50 (32) 0.80
Family function (APGAR), median (IQR), n 15 (13, 15), 230 15 (13, 15), 184 15 (13, 15), 46 0.59
Not in paid occupation 61/216 (28) 40/173 (23) 21/43 (49) <0.001
Full-/part-time student 48/230 (21) 37/184 (20) 11/46 (24) 0.57
Annual household income < Aust$100,401 128/222 (58) 99/180 (55) 29/42 (69) 0.10
Encounter economic hardshipb 78/234 (33) 59/187 (32) 19/47 (40) 0.25
No private health insurance 105/240 (44) 78 (41) 27/50 (54) 0.10
Own accommodation 113/237 (48) 90/189 (48) 23/48 (48) 0.97
Clinical
Co-morbidityc 85/244 (35) 65 (34) 20/54 (37) 0.70
Anxiety or depression (≥8 on HADS anxiety/depression subscale) 79/229 (34) 58/181 (32) 21/48 (44) 0.13
Disability (WHODAS), median (IQR), n 2 (1, 7), 238 2 (1, 6), 190 5 (1, 12), 48 0.02
Epilepsy-related
Symptomatic 91 (35) 68 (36) 23 (33) 0.71
Seizure frequency more than several times per year 71/209 (34) 58/168 (35) 13/41 (32) 0.73
Number of AEDs ≥2 20/253 (8) 13/188 (7) 7/65 (11) 0.32
Family history of epilepsy 47/224 (21) 35/176 (20) 12/48 (25) 0.44
≥8 weeks for neurologist review 41/239 (17) 38/183 (21) 3/56 (5) 0.007
Perceived stigmad 55/233 (24) 46/187 (25) 9/46 (20) 0.47
IQR denotes interquartile range, WHO-AUDIT-c World Health Organization’s Alcohol Use Disorders Identiﬁcation Test alcohol consumption part, Family APGAR
Family Adaptation, Partnership, Growth, Aﬀection and Resolve questionnaire, HADS Hospital Anxiety and Depression Scale, WHODAS World Health Organization’s
Disability Assessment Schedule. The P values are for the comparisons of the study group with those lost to follow-up or those who had invalid WHODAS assessments.
Kruskal-Wallis and Chi squared tests were used for continuous and categorical variables, respectively. If there were missing values, the actual denominators were
presented.
a Versus no current partner (i.e. never married, widowed, divorced or separated but not divorced).
b Either an instance of a household`s inability to make a necessary household payment (i.e. gas, electricity or telephone bills, heat or cool home, mortgage or rent
payments, etc.) or the demonstration of dissaving behavior (i.e. borrowing or use of savings, sell assets, borrow money, etc.).
c Includes self-reported cardiovascular, respiratory, ophthalmology, otorhinolaryngology, gastrointestinal, hepatic, renal, genito-urinary, musculoskeletal and
endocrine-metabolic diseases, but not including neurological (e.g. epilepsy) and psychiatric/behavioral diseases.
d As a result of epilepsy, the participants think that other people are uncomfortable, treat them diﬀerently or prefer to avoid them.
Table 2
Multivariable linear regression for associations with disability at 12 months
after adjustment of age, gender and co-morbidity.
Variable at baseline or intercept Parameter
estimatea
Standard
error
P-value
Intercept 0.0746 0.1922 0.70
Age, per 1 year increase 0.0048 0.0039 0.21
Female 0.1554 0.1196 0.20
Co-morbidityb 0.1548 0.1465 0.29
No tertiary education 0.2449 0.1215 0.05
Encounter economic hardshipc 0.3824 0.1293 0.004
Disability (WHODAS), per 1
point increase
0.0722 0.0103 <0.001
Number of AEDs ≥2 0.6015 0.2561 0.02
AEDs denotes anti-epileptic drugs.
a Log-transformed due to right skewness of raw data. Disability at 12 months
(WHODAS) = e 0.0746 + 0.0048*Age + 0.1554*Female + 0.1548*Co−morbidity + 0.2449*No
tertiary education + 0.3824*Encounter economic hardship + 0.0722*Disability at baseline (WHODAS) +
0.6015*Number of AEDs ≥2 -1. This model explains 38.3% of the variability of dis-
ability at 12 months measured on WHODAS.
b Includes self-reported cardiovascular, respiratory, ophthalmology, otorhi-
nolaryngology, gastrointestinal, hepatic, renal, genito-urinary, musculoskeletal
and endocrine-metabolic diseases, but not including neurological (e.g. epilepsy)
and psychiatric/behavioral diseases.
c Either an instance of a household`s inability to make a necessary household
payment (i.e. gas, electricity or telephone bills, heat or cool home, mortgage or
rent payments, etc.) or the demonstration of dissaving behavior (i.e. borrowing
or use of savings, sell assets, borrow money, etc.).
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than those with mental health disorders, but higher than those free of
any health problems (although, epilepsy and other neurological con-
ditions were not included as physical disorders in that study). The
SEISMIC data are also comparable to results of a study of people with a
variety of brain disorders: similar proportions of people with epilepsy
had problems with daily work, concentration, learning, activities, mo-
bility and household tasks [29]. However, the frequency of our parti-
cipants reporting disability was lower than in people with spinal cord
injury [32], multiple sclerosis [29], Parkinson`s disease [29], mental
illness [29,33], and substance abuse [33].
Lower education level has been associated with a “moderate or
higher level of disability” (i.e. scores> 26, after re-scaling on a 100
point scale) among a sample of elderly Polish people [34]. Being
wealthy had lower odds of “severe disability” (i.e. over 90th percentile),
among older adults in South Africa, where the measurement of wealth
(types of ﬂoors and walls, access to water, ownership of bicycles, in-
ternet and refrigerators, etc) [35] and “economic hardship” in our study
both measured households` ﬁnancial circumstances by incorporating a
range of economic aspects in day-to-day life.
There are few studies of disability and functional impairment in
people with newly diagnosed epilepsy. Thirteen percent (24 partici-
pants, data not shown) of our study group had WHODAS scores> 9,
indicating clinically signiﬁcant disability [31], which is a comparable
proportion that seen (10%) in the normative Australia data [31].
However, we were unable to build a stable logistic regression model to
identify these cases, who may have clinically signiﬁcant disability [31],
because we adjusted for age, sex and co-morbidity [31], and> 30 cases
are required to avoid over-ﬁtting (i.e. a minimum of 10 cases per in-
dependent variable) [36].
Most of the SEISMIC participants reported emotional diﬃculties
Fig. 1. Distribution of psychosocial disability measured using the 12-item World Health Organization Disability Assessment Schedule (WHODAS) at baseline and 12
months.
Fig. 2. Baseline predictors of being emotionally aﬀected by health
problems at 12 months.
Experiencing economic hardship was deﬁned by an instance of a
household`s inability to make a necessary household payment
(e.g. gas, electricity or telephone bills, heat or cool home, mort-
gage or rent payments) or the demonstration of dissaving behavior
(e.g. borrowing or use of savings, sell assets, borrow money).
Perceived stigma was determined by a single question: as a result
of epilepsy, whether participants thought that other people are
uncomfortable, treat them diﬀerently or prefer to avoid them.
Being emotionally aﬀected by health problems is one of the 12
World Health Organization Disability Assessment Schedule
(WHODAS) items.
The size of bars and numbers in bars show the frequency of par-
ticipants with and without a particular baseline characteristic that
reported a corresponding severity of being emotionally aﬀected by
health problems at 12 months.
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early (baseline, 76%) and late (12 months, 50%) after a diagnosis of
epilepsy. This is consistent with an earlier UK general practice study,
where 47% of 192 participants reported some degree of negative
emotional impact within 3 years of diagnosis [37]. Another European
study indicated that 74% of those with epilepsy had some emotional
diﬃculties reported on the WHODAS [29]. Evidence based upon eight
randomized control trials showed that psychological treatments (i.e.
epilepsy education, nurse-led counselling, cognitive, memory and self-
management training, and cognitive behavioral and mindfulness
therapy) enhanced emotional well-being in adults and adolescents with
epilepsy [38]. Our ﬁnding that the mood of participants improved over
time is similar to the attenuation of anxiety [39,40], and other forms of
emotional distress [41], seen in those with acute stroke [40], newly
diagnosed multiple sclerosis [39], and rheumatoid arthritis [41].
Our study suggests that interventions to manage the psychological
sequelae of epilepsy and other external stressors, such as economic
hardship and perceived stigma, may be needed to improve adjustment
and clinical management of this common condition. Financial stress/
strain is a strong risk factor for depression in epilepsy [42,43], and
almost one-third of our participants encountered economic hardship at
baseline. Financial costs peak in the ﬁrst year after diagnosis [15],
mostly related to the cost of investigations [44]. Lost wage-based pro-
ductivity associated with epilepsy is nearly equal to the combined wage
losses associated with diabetes, depression, anxiety, and asthma [45].
Equally, perceived stigma has previously been associated with de-
pression [43,46] and anxiety [47]. The ﬁnding that one quarter of
SEISMIC participants reporting perceived stigma is lower than in a
Korean cohort, where 69% reported keeping their diagnosis secret from
others [48], while 90% of those in Turkish study reported stigma as the
main reason to conceal their diagnosis from others [49]. Educational
videos and peer support groups may be useful in reducing epilepsy-
related stigma [50,51].
Key strengths of this study are the prospective assessment of a broad
range of health outcomes using validated tools in adults recruited from
a variety of health centers early after the diagnosis and over the ensuing
12 months. Even so, we acknowledge 27% attrition and selection bias
may have inﬂuenced participation and follow-up assessments, reﬂected
in those with higher baseline WHODAS scores and those unemployed
being more likely to be lost to follow-up or excluded from the study
because of incomplete or missing WHODAS data. This may have led to
an underestimate of overall disability and the degree of emotional
diﬃculties, as lower baseline WHODAS scores were associated with
lower follow-up scores and unemployment was associated with de-
pression [43]. Our results may have been inﬂuenced by recall bias, as
over two thirds of the participants had their baseline interviews com-
pleted more than 28 days after diagnosis. Answers to questionnaires,
especially to psychosocial items (e.g. WHO-AUDIT-c, APGAR, HADS,
WHODAS), may have been inﬂuenced by the presence of a proxy for
the<10% who had one present. Furthermore, because the WHODAS
assessed disability “in the past 30 days”, for those participants who had
baseline interviews completed within 30 days after diagnosis, this may
include certain period before the diagnosis. Our sample was also too
small to validate our model in a split sample approach.
5. Conclusion
In summary, our study has provided an overview of the spectrum of
disability after a diagnosis of epilepsy, and re-emphasized the im-
portance of emotional adjustment. Emotional problems were by far the
most commonly reported disability after a diagnosis of epilepsy.
Although many people showed recovery, there was a large proportion
with new and ongoing problems at 12 months. Services targeting psy-
chological support for people with epilepsy, including the incorporation
of economic hardship and stigma reduction, may be needed to improve
recovery and management of this common condition. People with
epilepsy may be encouraged to contact their general practitioners and
community services if any disabilities are of concern, and may be
educated on strategies for saving, planning ahead, and provided in-
formation on available ﬁnancial supports. Educational videos and
pamphlets helping epilepsy patients achieve correct understanding of
the disease and peer support groups enhancing social supports may
reduce perceived stigma.
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